MedPath
NMPA Approval

Rifandine Capsules

国药准字H32025419

January 15, 2016

Drug Information

利福定胶囊

胶囊剂

0.15g

化学药品

January 15, 2016

Company Information

Applicant Company

江苏省扬州市李典镇新坝吴桥

Manufacturing Company

江苏省扬州市李典镇新坝吴桥

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利福定胶囊 - NMPA 批准文号 | MedPath